Living With HIV For People Over 50 Years.
One January era in 1991, occupation lady of the press Jane Fowler, then 55, opened a communication from a health insurance company informing her that her request for coverage had been denied due to a "significant blood abnormality". This was the inception inkling - later confirmed in her doctor's shtick - that the Kansas City, Kan, best had contracted HIV from someone she had dated five years before, a mortals she'd been friends with her unmixed adult life treatment. She had begun seeing him two years after the end of her 24-year marriage.
Fowler, now 75 and bracing thanks to the advent of antiretroviral medications, recalls being devastated by her diagnosis. "I went quarters that light of day and literally took to my bed. I thought, 'What's growing to happen?'" she said. For the next four years Fowler, once an animated and successful writer and editor, lived in what she called "semi-isolation," staying mostly in her apartment. Then came the dawning establishment that her isolation wasn't portion anyone, least of all herself.
Fowler slowly began reaching out to experts and other older Americans to be taught more about living with HIV in life's later decades. By 1995, she had helped co-found the National Association on HIV Over 50. And through her program, HIV Wisdom for Older Women, Fowler today speaks to audiences nationwide on the challenges of living with the virus. "I incontestable to symbolize out - to put an old, wrinkled, white, heterosexual physiognomy to this disease," she said. "But my dispatch isn't age-specific: We all insufficiency to dig that we can be at risk".
That implication may be more high-priority than ever this Wednesday, World AIDS Day. During a up to date White House forum on HIV and aging, at which Fowler spoke, experts presented untrained data suggesting that as the HIV/AIDS universal enters its fourth decade those afflicted by it are aging, too.
One report, conducted by the AIDS Community Research Initiative of America (ACRIA), distinguished that 27 percent of Americans diagnosed with HIV are now ancient 50 or older and by 2015 that part could double. Why? According to Dr Michael Horberg, immorality seat of the HIV Medicine Association, there's been a societal "perfect storm" that's led to more HIV infections among consumers in middle age or older.
And "Certainly the rise of Viagra and equivalent drugs to treat erectile dysfunction, population are getting more sexually active because they are more able to do so," Horberg said. There's also the appreciation that HIV is now treatable with complex drug regimens, he said, even though these medicines often come with onerous subsidiary effects. For her part, Fowler said that more and more aging Americans hit upon themselves recently divorced (as she did) or widowed and back in the dating game.
Saturday, July 27, 2013
Saturday, July 20, 2013
Omnitarg And Herceptin Could Save Women Without Chemotherapy From Breast Cancer
Omnitarg And Herceptin Could Save Women Without Chemotherapy From Breast Cancer.
Combinations of targeted therapies for an especially pushy specimen of core cancer could potentially usher the maturity of affected patients into remission, researchers at a major titty cancer meeting said Friday. Presenting results from three trials at the annual San Antonio Breast Cancer Symposium, scientists explained that administering two or more drugs designed to bonus HER2-positive tumors resulted in much higher release rates than doses of any one dull or paragon chemotherapy alone medrxcheck.net. Given to patients several weeks before cancer surgery, with or without chemotherapy, the medications often shrank tumors dramatically or eradicated them altogether, the researchers said.
HER2-positive cancer is sharp to a protein called humane epidermal excrescence constituent receptor 2, which promotes the growth of malignant cells. Drugs that specifically quarry HER2 cells - including Herceptin, Tykerb and Omnitarg - have been proven moving on these types of tumors, which wait on to be more aggressive than other breast cancers. "I consider it's a very exciting era, because we've gone from a very lethal cycle - to a point where we might be able to cure this disease," said Dr Neil Spector, a professor of nostrum at Duke University Medical Center, who moderated the symposium session.
Using Tykerb and Herceptin combined with chemotherapy before surgery, researchers followed 2,500 women with prematurely mamma cancer at 85 facilities throughout Germany. About half of these patients achieved excuse before surgery, said Dr Michael Untch, fountain-head of the multidisciplinary knocker cancer worry at Helios Clinic in Berlin. "In a majority of these patients, we could do breast-conserving surgery where beforehand they were candidates for mastectomy," Untch said.
The side will continue following the patients to see if remission at surgery affects their outcome. Another on showed the combination of Omnitarg and Herceptin, when given with the chemotherapy downer docetaxel, eradicated 46 percent of tumors, 50 percent more than the results achieved without Omnitarg. Also, 17 percent of tumors were eradicated by combining the two targeted drugs and skipping chemotherapy, the researchers said.
Combinations of targeted therapies for an especially pushy specimen of core cancer could potentially usher the maturity of affected patients into remission, researchers at a major titty cancer meeting said Friday. Presenting results from three trials at the annual San Antonio Breast Cancer Symposium, scientists explained that administering two or more drugs designed to bonus HER2-positive tumors resulted in much higher release rates than doses of any one dull or paragon chemotherapy alone medrxcheck.net. Given to patients several weeks before cancer surgery, with or without chemotherapy, the medications often shrank tumors dramatically or eradicated them altogether, the researchers said.
HER2-positive cancer is sharp to a protein called humane epidermal excrescence constituent receptor 2, which promotes the growth of malignant cells. Drugs that specifically quarry HER2 cells - including Herceptin, Tykerb and Omnitarg - have been proven moving on these types of tumors, which wait on to be more aggressive than other breast cancers. "I consider it's a very exciting era, because we've gone from a very lethal cycle - to a point where we might be able to cure this disease," said Dr Neil Spector, a professor of nostrum at Duke University Medical Center, who moderated the symposium session.
Using Tykerb and Herceptin combined with chemotherapy before surgery, researchers followed 2,500 women with prematurely mamma cancer at 85 facilities throughout Germany. About half of these patients achieved excuse before surgery, said Dr Michael Untch, fountain-head of the multidisciplinary knocker cancer worry at Helios Clinic in Berlin. "In a majority of these patients, we could do breast-conserving surgery where beforehand they were candidates for mastectomy," Untch said.
The side will continue following the patients to see if remission at surgery affects their outcome. Another on showed the combination of Omnitarg and Herceptin, when given with the chemotherapy downer docetaxel, eradicated 46 percent of tumors, 50 percent more than the results achieved without Omnitarg. Also, 17 percent of tumors were eradicated by combining the two targeted drugs and skipping chemotherapy, the researchers said.
Thursday, July 11, 2013
Overweight Has Become The Norm For American Women
Overweight Has Become The Norm For American Women.
Almost one-quarter of brood women who are overweight truly determine themselves as being normal weight, while a sizable minority (16 percent) of women at typical body weight actually concern that they're too fat, according to a new study. The study found these misperceptions to be often correlated with race: Black and Hispanic women were much more appropriate to leeway down their overweight status compared with whites, who were more apt to nettle that they weighed too much, even when they didn't inches men. Although the study looked mostly at low-income women attending public-health clinics in Texas, the findings do reproduction other studies in other populations, including a recent Harris Interactive/HealthDay poll.
That take the measure of found that 30 percent of adult Americans in the "overweight" type believed they were actually normal size, while 70 percent of those classified as stout felt they were simply overweight. Among the heaviest group, the morbidly obese, 39 percent considered themselves barely overweight. The problem, according to go into take author Mahbubur Rahman, is the "fattening of America," import that for some women, being overweight has become the norm.
And "If you go somewhere, you see all the overweight relations that think they are normal even though they're overweight," said Rahman, who is deputy professor of obstetrics and gynecology at the Center for Interdisciplinary Research in Women's Health, University of Texas Medical Branch at Galveston (UTMBG). In fact, "they may even be overweight or normal-weight and consider they are completely diminished compared to others," added ruminate on senior author Dr Abbey Berenson, impresario of the Center for Interdisciplinary Research in Women's Health at UTMBG.
The changed findings are published in the December issue of Obstetrics & Gynecology. The analysis looked at more than 2200 women who had arrived at a public-health clinic for reproductive assistance, such as obtaining contraceptives. According to the exploration authors, more than half of these reproductive-age women (20 to 39 years), who were the vassal of this trial, were above a standard body mass sign (BMI). An even higher proportion of black Americans (82 percent) and Mexican Americans (75 percent) were overweight or obese.
Almost one-quarter of brood women who are overweight truly determine themselves as being normal weight, while a sizable minority (16 percent) of women at typical body weight actually concern that they're too fat, according to a new study. The study found these misperceptions to be often correlated with race: Black and Hispanic women were much more appropriate to leeway down their overweight status compared with whites, who were more apt to nettle that they weighed too much, even when they didn't inches men. Although the study looked mostly at low-income women attending public-health clinics in Texas, the findings do reproduction other studies in other populations, including a recent Harris Interactive/HealthDay poll.
That take the measure of found that 30 percent of adult Americans in the "overweight" type believed they were actually normal size, while 70 percent of those classified as stout felt they were simply overweight. Among the heaviest group, the morbidly obese, 39 percent considered themselves barely overweight. The problem, according to go into take author Mahbubur Rahman, is the "fattening of America," import that for some women, being overweight has become the norm.
And "If you go somewhere, you see all the overweight relations that think they are normal even though they're overweight," said Rahman, who is deputy professor of obstetrics and gynecology at the Center for Interdisciplinary Research in Women's Health, University of Texas Medical Branch at Galveston (UTMBG). In fact, "they may even be overweight or normal-weight and consider they are completely diminished compared to others," added ruminate on senior author Dr Abbey Berenson, impresario of the Center for Interdisciplinary Research in Women's Health at UTMBG.
The changed findings are published in the December issue of Obstetrics & Gynecology. The analysis looked at more than 2200 women who had arrived at a public-health clinic for reproductive assistance, such as obtaining contraceptives. According to the exploration authors, more than half of these reproductive-age women (20 to 39 years), who were the vassal of this trial, were above a standard body mass sign (BMI). An even higher proportion of black Americans (82 percent) and Mexican Americans (75 percent) were overweight or obese.
Tuesday, July 2, 2013
Many Survivors Of Lymphoma Did Not Receive A Recommendation To Take Further Tests For Other Types Of Cancer
Many Survivors Of Lymphoma Did Not Receive A Recommendation To Take Further Tests For Other Types Of Cancer.
Many Hodgkin lymphoma survivors don't admit recommended support screening tests for other cancers, a redone examine finds. "Most Hodgkin lymphoma patients are cured, but they can be at endanger many years later of developing derivative cancers or other unpunctually effects of their primary treatment malaysia. This is why quality of follow-up care post-treatment is so important," dominant investigator Dr David Hodgson, a dispersal oncologist at the Princess Margaret Hospital Cancer Program in Toronto, Canada, said in a University Health Network dope release.
He and his colleagues followed 2071 survivors for up to 15 years after Hodgkin lymphoma diagnosis and found that 62,5 percent were not screened for colorectal cancer, 32,3 percent were not screened for core cancer, and 19,9 percent were not screened for cervical cancer. "Our results indicate that the optimal consolidation heedfulness did not happen, even though most patients had visits with both a immediate worry provider and an oncologist in years two through five.
Many Hodgkin lymphoma survivors don't admit recommended support screening tests for other cancers, a redone examine finds. "Most Hodgkin lymphoma patients are cured, but they can be at endanger many years later of developing derivative cancers or other unpunctually effects of their primary treatment malaysia. This is why quality of follow-up care post-treatment is so important," dominant investigator Dr David Hodgson, a dispersal oncologist at the Princess Margaret Hospital Cancer Program in Toronto, Canada, said in a University Health Network dope release.
He and his colleagues followed 2071 survivors for up to 15 years after Hodgkin lymphoma diagnosis and found that 62,5 percent were not screened for colorectal cancer, 32,3 percent were not screened for core cancer, and 19,9 percent were not screened for cervical cancer. "Our results indicate that the optimal consolidation heedfulness did not happen, even though most patients had visits with both a immediate worry provider and an oncologist in years two through five.
Subscribe to:
Posts (Atom)